VerImmune Inc Appoints Oncology Veteran as Interim Chief Business Officer

Published on :

VerImmune Inc Appoints Oncology Veteran as Interim Chief Business Officer A biotech industry veteran in oncology to lead business development and alliance-building efforts for VerImmune’s proprietary Anti-tumor Immune Redirection (AIR) platform Baltimore, Maryland – Feb 14th, 2020 – VerImmune, Inc., a privately-owned immuno-oncology biotechnology company developing a first-in-class broad-spectrum cancer therapy for solid tumors based on [….]

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers

Published on :

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers VerImmune’s Novel technology platform enables redirection of pre-existing natural immunity towards fighting cancer BALTIMORE (Originally Published via PRWEB) JANUARY 13, 2020 VerImmune Announces New Board, Advisors and Officers VerImmune, a privately-owned immuno-oncology biotechnology company developing a first-in-class broad spectrum [….]